Cargando…
Impact of perioperative chemotherapy in the treatment of patients with gastric cancer
BACKGROUND: Perioperative chemotherapy (PeriCh) is the current standard of care for stage II/III gastric cancer tumors in Europe. However, when it concerns patients who endure complications during PeriCh it is unclear if it increases the risk of postoperative complications and other poorer surgical...
Autores principales: | Fonseca, Telma, Coimbra, Mariana, Santos-Sousa, Hugo, Barbosa, Elisabete, Barbosa, José |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10158857/ https://www.ncbi.nlm.nih.gov/pubmed/37152082 http://dx.doi.org/10.1097/j.pbj.0000000000000180 |
Ejemplares similares
-
MORBIDITY AND SURVIVAL AFTER PERIOPERATIVE CHEMOTHERAPY IN GASTRIC CANCER: A STUDY USING THE BECKER’S CLASSIFICATION AND REGRESSION
por: MACHADO, Maria Cecília de Aguiar, et al.
Publicado: (2023) -
Impact of the COVID-19 pandemic on surgical treatment of colon cancer in a University Hospital
por: Fonseca, Telma, et al.
Publicado: (2022) -
Impact of Postoperative Chemotherapy in Patients with Gastric/Gastroesophageal Adenocarcinoma Treated with Perioperative Chemotherapy
por: Ballhausen, Alexej, et al.
Publicado: (2022) -
Perioperative versus total neoadjuvant chemotherapy in gastric cancer
por: Yang, Jessica, et al.
Publicado: (2023) -
Safety and preliminary results of perioperative chemotherapy and hyperthermic intraperitoneal chemotherapy (HIPEC) for high-risk gastric cancer patients
por: Costa, Wilson L, et al.
Publicado: (2012)